20-F/AAMENDMENTCMNDCIK 0001892500

Clearmind Medicine Inc.

Name: SEC EDGAR filing 0001213900-24-023593
Creator: Clearmind Medicine Inc.
License: https://www.usa.gov/government-works

Foreign annual (20-F/A) filed March 18, 2024.

Annual report filed by foreign private issuers listed on U.S. exchanges.

Read the filing on SEC.gov All documents in this filing

New to the 20-F/A? What it is and how to read one

Filing facts

Accession number: 0001213900-24-023593
Filer: Clearmind Medicine Inc.
Ticker: CMND
CIK: 0001892500
Form type: 20-F/A
Form description: Foreign annual
Filed at: March 18, 2024
Period of report: October 31, 2023
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 6.1 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Clearmind Medicine Inc.

See all 39 filings from Clearmind Medicine Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1892500/000121390024023593/0001213900-24-023593-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Clearmind Medicine Inc. (0001892500) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.